{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:16:21Z","timestamp":1788970581415,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.soncn.2026.152262","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:57:42Z","timestamp":1781668662000},"page":"152262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lived Experience of Patients with Myeloproliferative Neoplasm: An Interpretative Phenomenological Study"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-8864","authenticated-orcid":false,"given":"Daniela","family":"Berardinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-1818","authenticated-orcid":false,"given":"Sara","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7068-4734","authenticated-orcid":false,"given":"Francesca","family":"Cotardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-7479","authenticated-orcid":false,"given":"Sara","family":"Carletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6294-9834","authenticated-orcid":false,"given":"Silvia","family":"Gonella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-8692","authenticated-orcid":false,"given":"Paola Di","family":"Giulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Costamagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-3481","authenticated-orcid":false,"given":"Valerio","family":"Dimonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-981X","authenticated-orcid":false,"given":"Carmen","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soncn.2026.152262_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.soncn.2026.152262_bib0002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.23690","article-title":"How common are myeloproliferative neoplasms? A systematic review and meta-analysis","volume":"89","author":"Titmarsh","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.soncn.2026.152262_bib0003","article-title":"Risk of cardiovascular and cerebrovascular diseases in patients with myeloid neoplasms: results from 1.8 million inhabitants of North-West Italy","author":"Catalano","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.soncn.2026.152262_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-016-2208-2","article-title":"Myeloproliferative neoplasms (MPNs) have a significant impact on patients\u2019 overall health and productivity: the MPN Landmark survey","volume":"16","author":"Mesa","year":"2016","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2026.152262_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/10428194.2018.1480768","article-title":"Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?","volume":"60","author":"Langlais","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.soncn.2026.152262_bib0006","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2021.1944096","article-title":"Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions","volume":"14","author":"Yoon","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"16","key":"10.1016\/j.soncn.2026.152262_bib0007","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","article-title":"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis","volume":"124","author":"Tefferi","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.soncn.2026.152262_bib0008","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3109\/10428194.2014.983098","article-title":"Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors","volume":"56","author":"Mesa","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.soncn.2026.152262_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101372","article-title":"Addressing symptom burden in myeloproliferative neoplasms","volume":"35","author":"Tremblay","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1016\/j.soncn.2026.152262_bib0010","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s12325-020-01314-0","article-title":"The myeloproliferative neoplasm landscape: a patient\u2019s eye view","volume":"37","author":"Petruk","year":"2020","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.soncn.2026.152262_bib0011","article-title":"Disabled, invisible and dismissed-the lived experience of fatigue in people with myeloproliferative neoplasms","volume":"6","author":"Bradford","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"issue":"7-8","key":"10.1016\/j.soncn.2026.152262_bib0012","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jocn.15944","article-title":"Daily living and rehabilitation needs in patients and caregivers affected by myeloproliferative neoplasms (MPN): a qualitative study","volume":"31","author":"Rossau","year":"2022","journal-title":"J Clin Nurs"},{"issue":"6","key":"10.1016\/j.soncn.2026.152262_bib0013","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11136-018-1827-2","article-title":"Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-results from the Italian \u201cBack to Life\u201d project","volume":"27","author":"Palandri","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.soncn.2026.152262_bib0014","unstructured":"Smith JA, Flowers P, Larkin M. Interpretative Phenomenological Analysis: Theory, Method and Research. London, UK: SAGE Publications Ltd; 2021. 2nd ed."},{"key":"10.1016\/j.soncn.2026.152262_bib0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/jehp.jehp_1010_22","article-title":"Persistent suffering: Living experiences of patients with rare disease: an interpretative phenomenological study","volume":"12","author":"Rezaei","year":"2023","journal-title":"J Educ Health Promot"},{"issue":"6","key":"10.1016\/j.soncn.2026.152262_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"10.1016\/j.soncn.2026.152262_bib0017","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12885-019-5764-4","article-title":"Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018","volume":"19","author":"Mej\u00eda-Ochoa","year":"2019","journal-title":"BMC Cancer"},{"issue":"7000","key":"10.1016\/j.soncn.2026.152262_bib0018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.311.7000.299","article-title":"Qualitative research. Introducing focus groups","volume":"311","author":"Kitzinger","year":"1995","journal-title":"BMJ"},{"issue":"37","key":"10.1016\/j.soncn.2026.152262_bib0019","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7748\/ns.29.37.44.e8822","article-title":"Focus group research","volume":"29","author":"Traynor","year":"2015","journal-title":"Nurs Stand"},{"issue":"4","key":"10.1016\/j.soncn.2026.152262_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qual Health Res"},{"key":"10.1016\/j.soncn.2026.152262_bib0021","unstructured":"ATLAS.ti Scientific Software Development GmbH. ATLAS.ti [computer software]. Berlin, Germany: ATLAS.ti Scientific Software Development GmbH. Available at: https:\/\/atlasti.com. Accessed February 20, 2026."},{"issue":"1-2","key":"10.1016\/j.soncn.2026.152262_bib0022","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2702.2009.02896.x","article-title":"Translation and back-translation in qualitative nursing research: methodological review","volume":"19","author":"Chen","year":"2010","journal-title":"J Clin Nurs"},{"issue":"2","key":"10.1016\/j.soncn.2026.152262_bib0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/hex.12640","article-title":"How to practice person-centred care: a conceptual framework","volume":"21","author":"Santana","year":"2018","journal-title":"Health Expect"},{"key":"10.1016\/j.soncn.2026.152262_bib0024","series-title":"Qualitative Research & Evaluation Methods: Integrating Theory and Practice","author":"Patton","year":"2015"},{"issue":"5","key":"10.1016\/j.soncn.2026.152262_bib0025","first-page":"436","article-title":"Identity loss and maintenance: commonality of experience in cancer and dementia","volume":"13","author":"Gillies","year":"2004","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.soncn.2026.152262_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102713","article-title":"Living with a chronic hematological malignancy: perspectives on PRO-based management of symptoms","volume":"73","author":"Pedersen","year":"2024","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.soncn.2026.152262_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2025.102855","article-title":"The role of psychosocial adjustment in the quality of life of patients with myeloproliferative neoplasms","volume":"76","author":"Eppingbroek","year":"2025","journal-title":"Eur J Oncol Nurs"},{"issue":"11","key":"10.1016\/j.soncn.2026.152262_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000966","article-title":"Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study","volume":"7","author":"Mesa","year":"2023","journal-title":"Hemasphere"},{"issue":"10","key":"10.1016\/j.soncn.2026.152262_bib0029","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ajh.24098","article-title":"Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls","volume":"90","author":"Anderson","year":"2015","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.soncn.2026.152262_bib0030","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1080\/10428194.2022.2113531","article-title":"Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study","volume":"63","author":"Ritchie","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.soncn.2026.152262_bib0031","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00277-017-3082-y","article-title":"The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey","volume":"96","author":"Harrison","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.soncn.2026.152262_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2023.102421","article-title":"Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives","volume":"67","author":"Hewison","year":"2023","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"10.1016\/j.soncn.2026.152262_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.001","article-title":"The associations of socioeconomic status, social activities, and loneliness with depressive symptoms in adults aged 50 years and older across 24 countries: findings from five prospective cohort studies","volume":"5","author":"Wang","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"10.1016\/j.soncn.2026.152262_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263672","article-title":"Incurable but treatable: understanding, uncertainty and impact in chronic blood cancers-a qualitative study from the UK\u2019s Haematological Malignancy Research Network","volume":"17","author":"Howell","year":"2022","journal-title":"PLoS One"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126001427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126001427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:49:23Z","timestamp":1788968963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208126001427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0749208126001427"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152262","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lived Experience of Patients with Myeloproliferative Neoplasm: An Interpretative Phenomenological Study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152262"}}